Skip to main content
SpringerLink
Log in

The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The immunosuppressive effects of a leukotriene B4 (LTB4) receptor antagonist, ONO4057, on liver allotransplantation in rats were evaluated, and the levels of prostaglandin E2 (PGE2) in the liver tissue during rejection of the allografts examined. The rats were divided into four groups: group 1: Lewis rats (LEW) given a sham operation with dimethyl sulfoxide (DMSO); group 2: LEW given syngenic orthotopic liver transplantation (OLT) from LEW, with DMSO; group 3: LEW given allogenic OLT from ACI rats (ACI), with DMSO; and group 4: LEW given allogenic OLT from ACI, with ONO4057 as 10, 30, or 100 mg/kg per day dissolved in DMSO to subgroups 4a, 4b, and 4c, respectively. Histological examinations were performed, survival times monitored, and liver tissue PGE2 levels 3, 5, 7, and 14 days after transplantation measured. The mean graft survival times in groups 4a, b, and c, at 37.5±10.4, 52.2±24.4, and 34.0±4.9 days (mean±SEM), respectively, were significantly longer than that in group 3 (at 13.0±3.2 days). Moreover, the levels of tissue PGE2 in the liver allografts in group 4a were significantly higher than those in group 3 on days 5 and 7. These results suggest that ONO4057 has an immunosuppressive effect on liver allotransplantation since it reduces the activities of LTB4 which augments immune responses, and also because it indirectly increases the PGE2 level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Graddock GN, Pentlow BD (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323–1327

    Google Scholar 

  2. Starzl TE, Iwatsuki S, Thiel DHV, Gartner JC, Zitelli BJ, Malatack JJ, Schade RR, Shaw BW Jr, Hakala TR, Rosenthal JT, Porter KA (1982) Evolution of liver transplantation. Hepatology 2:614–636

    Google Scholar 

  3. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK506 for liver, kidney, and pancreas transplantation. Lancet II 8670:1000–1004

    Google Scholar 

  4. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 32:488–489

    Google Scholar 

  5. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1:470–471

    Google Scholar 

  6. McCauley J, Fung J, Jain A, Todo S, Starzl TE (1990) The effects of FK 506 on renal function after liver transplantation. Transplant Proc 22:17–20

    Google Scholar 

  7. Kumano K, Wang G, Endo T, Kuwao S (1991) FK506-induced nephrotoxicity in rats. Transplant Proc 23:512–515

    Google Scholar 

  8. Konishi K, Watanabe T, Yabushita K, Hirosawa H, Izumi R, Miyazaki I (1991) Effect of lipoxygenase inhibitor (nordihydroguaiaretic acid, NDGA) on canine pancreatic allografts. Transplant Proc 23:1681–1682

    Google Scholar 

  9. Horichi H, Izumi R, Shimizu K, Konishi K, Kitabayashi K, Watanabe T, Miyazaki I (1991) Effect of 5-lipoxygenase inhibitor on canine pancreatic allotransplantation. Transplant Proc 23:1679–1680

    Google Scholar 

  10. Kamei T, Callery MP, Flye MW (1991) Intragraft delivery of 16,16-dimethyl PGE2 induces donor-specific tolerance in rat cadiac allograft recipients. Transplantation 51:242–246

    Google Scholar 

  11. Anderson CB, Jeffee BM, Graff RJ (1977) Prolongation of murine skin allografts by prostaglandin E. Transplantation 23:444–447

    Google Scholar 

  12. Mangino MJ, Jendrisak MD, Brunt E, Anderson CB (1988) Eicosanoid synthesis inhibition and renal allograft function during acute rejection. Transplantation 45:902–907

    Google Scholar 

  13. Perez RV, Babcock GF, Alexander JW (1989) Immunoregulation of transfusion-induced immunosuppression with inhibitors of the arachidonic acid metabolism. Transplantation 48:85–87

    Google Scholar 

  14. Goodwin JS, Bankhurst AD, Messner RP (1977) Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 146:1719–1734

    Google Scholar 

  15. Jordan ML, Hoffman RA, Debe EF, West MA, Simmons RL (1987) Prostaglandin E2 mediates subset-specific effects on the functional responses of allosensitized T lymphocyte clones. Transplantation 43:117–123

    Google Scholar 

  16. Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155:943–948

    Google Scholar 

  17. Synder DS, Beller DI, Unanue ER (1982) Prostaglandins modulate macrophage Ia expression. Nature 299:163–165

    Google Scholar 

  18. Payan DG, Goldman DW, Goetzl EJ (1984) Biochemical and cellular characteristics of the regulation of human leukocyte function by lipoxygenase products of arachidonic acid. In: Charkrin LW, Bailey DM (ed) The leukotrienes, chemistry and biology. Academic, Orlando, pp 231–245

    Google Scholar 

  19. Smith MJH, ford-Hutchinson AW, Bray MA (1980) Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol 32:517–518

    Google Scholar 

  20. Atluru D, Goodwin JS (1986) Leukotriene B4 causes proliferation of interleukin 2-dependent T cells in the presence of suboptimal levels of interleukin 2. Cell Immunol 99:444–452

    Google Scholar 

  21. Jordan ML, Hoffman RA, Simmons RL (1986) Leukotriene B4 (LTB4) augments IL2-dependent proliferation of T lymphocyte clones. Transplant Proc 18:224–227

    Google Scholar 

  22. Pleszczynski MR, Lemaire I (1985) Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 135:3958–3961

    Google Scholar 

  23. Pleszczynski MR, Chavaillaz PA, Lemaire I (1986) Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukot Essent Fatty Acids 23:207–210

    Google Scholar 

  24. Pleszczynski MR, Gagnon L, Sirois P (1983) Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun 113:531–537

    Google Scholar 

  25. Webb DR, Nowowiejski I, Healy C, Rogers TJ (1982) Immunosuppressive properties of leukotriene D4 and E4 in vitro. Biochem Biophys Res Commun 104:1617–1622

    Google Scholar 

  26. Johnson HM, Torres BA (1984) Leukotrienes: positive signals for regulation of γ-interferon production. J Immunol 132:413–416

    Google Scholar 

  27. Bisgaard H, Helqvist S, Boudet L, Venge P, Dahl R, Sondergaard J (1986) Chemotactic activity of LTB4 in man. Allergy 41:365–372

    Google Scholar 

  28. Dahlen SE, Bjork J, Hedqvist P, Arfors KE, Hammarstrom S, Lindgren JA, Samuelsson B (1981) Leukotrienes promote plasma leakage and leukocyte adhesion in postcapaillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 78:3887–3891

    Google Scholar 

  29. Feuerstein G (1985) Autonomic pharmacology of leukotrienes. J Auton Pharmacol 5:149–168

    Google Scholar 

  30. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK (1985) The relation of leukotrienes to liver injury. Hepatology 5:883–891

    Google Scholar 

  31. Trudell JR, Bendix M, Bosterling B (1984) Hypoxia potentiates killing of hepatocyte monolayers by leukotrienes, hydroperoxyeicosatetraenoic acids, or calcium ionophore A23187. Biochem Biopys Acta 803:338–341

    Google Scholar 

  32. Stachura J, Tarnawski A, Szczudrawa J, Bogdal J, Mach T, Klimczyk B, Kirchmayer S (1980) Cytoprotective effect of 16,16'dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat. Folia Histchem Cytobiol 18:311–317

    Google Scholar 

  33. Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B (1981) Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81:211–217

    Google Scholar 

  34. Iyobe T, Izumi R, Shimizu K (1993) The immunosuppressive effect of 5-lipoxigenase inhibitor on liver allotransplantation in rats. Transplantation 56:518–523

    Google Scholar 

  35. Yoshimoto T, Yokoyama C, Ochi K, Yamamoto S, Maki Y, Ashida Y, Terao S, Shiraishi M (1982) 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochem Biophys Acta 713:470–473

    Google Scholar 

  36. Ashida Y, Saijo T, Kuriki H, Makino H, Terao S, Maki Y (1983) Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostaglandins 26:955–972

    Google Scholar 

  37. Kishikawa K, Matsunaga N, Maruyama T, Seo R, Toda M, Miyamoto T, Kawasaki A (1990) ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist. Adv Prostaglandin Thromboxane Leukot Res 21:407–410

    Google Scholar 

  38. Kishikawa K, Tateishi N, Maruyama T, Seo R, Toda M, Miyamoto T (1992) ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions. Prostaglandins 44:261–275

    Google Scholar 

  39. Kamada N, Calne RY (1979) Orthotopic liver transplantation in the rat. Transplantation 28:47–50

    Google Scholar 

  40. Kamada N, Sumimoto R, Kaneda K (1992) The value of hepatic artery reconstruction as a technique in rat liver transplantation. Surgery 111:195–200

    Google Scholar 

  41. David NA (1972) The pharmacology of dimethyl sulfoxide 6544. Annu Rev Pharmacol Toxicol 12:353–374

    Google Scholar 

  42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  43. Nonomura A, Mizukami Y, Matsubara F, Kobayashi K (1991) Clinicopathological study of lymphocyte attachment to endothelial cells (endothelialitis) in various liver diseases. Liver 11:78–87

    Google Scholar 

  44. Hagmann W, Steffan AM, Kirn A, Keppler D (1987) Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology 7:732–736

    Google Scholar 

  45. Hanada K, Mitsuhashi Y, Hashimoto I (1992) Inhibitory effect of the leukotriene B4 receptor antagonist against hypomagnesic diet-induced dermatitis in hairless rats. J Dermatol (Tokyo) 19:456–460

    Google Scholar 

  46. Fretland DJ, Widomski DL, Zemaitis JM, Walsh RE, Levin S, Djuric SW, Shone RL, Tsai BS, Gaginella TS (1990) Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist, SC-41930. Inflammation 14:727–739

    Google Scholar 

  47. Sinclair S, Levy G (1990) Eicosanoids and the liver. Ital J Gastroenterol 22:205–213

    Google Scholar 

  48. Keppler D, Huber M, Baumart T (1988) Leukotrienes as mediators in diseases of the liver. Sem Liv Dis 8:357–366

    Google Scholar 

  49. Powell WS (1984) Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem 259:3082–3089

    Google Scholar 

  50. Harper TW, Garrity MJ, Murphy RC (1986) Metabolism of leukotriene B4 in isolated rat hepatocytes. J Biol Chem 261:5414–5418

    Google Scholar 

  51. Crooke ST, Mong S, Sarau HM, Winkler JD, Vegesna VK (1988) Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes. Ann New York Acad Sci 524:153–161

    Google Scholar 

  52. Ford-Hutchinson AW (1985) Leukotrienes: Their formation and role as inflammatory mediators. Fed Proc 44:25–29

    Google Scholar 

  53. Flower RJ (1978) Steroidal antiinflammatory drugs as inhibitors of phospholipase A2. Adv Prostaglandin Thromboxane Res 3:105–112

    Google Scholar 

  54. Moncada S, Flower R, Vane J (1980) Prostaglandins, prostacyclin and thromboxane A2. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. MacMillan, New York, pp 668–681

    Google Scholar 

  55. Decker K, Birmelin M (1984) Ca2+ mediates phagocytosis-evoked icosanoid synthesis in Kupffer cells. In: Braque P, Garay RP, Frolich JC, Nicosia S (eds) Prostaglandins and membrane ion transport. Raven, New York, pp 113–118

    Google Scholar 

  56. Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, Kuehl FA Jr (1983) Inhibition by prostsglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 80:4349–4353

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Surgery, School of Medicine, Kanazawa University, 13-1 Takaramachi, 920, Kanazawa, Japan

    Toru Ii, Ryohei Izumi & Koichi Shimizu

Authors
  1. Toru Ii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryohei Izumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Koichi Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ii, T., Izumi, R. & Shimizu, K. The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats. Surg Today 26, 419–426 (1996). https://doi.org/10.1007/BF00311929

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00311929

Key Words

Search

Navigation